Back to top
Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 6th:

Vantiv, Inc. (VNTV - Free Report) : This electronic payment processing services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.

Vantiv has a PEG ratio 1.46, compared with 1.61 for the industry. The company possesses a Growth Score of A.

Vantiv, Inc. PEG Ratio (TTM)

Vantiv, Inc. peg-ratio-ttm | Vantiv, Inc. Quote

Virtus Investment Partners, Inc. (VRTS - Free Report) : This publicly owned investment manager, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.

Virtus Investment Partners has a PEG ratio 0.98, compared with 1.22 for the industry. The company possesses a Growth Score of A.

Broadridge Financial Solutions, Inc. (BR - Free Report) : This investor communications solutions provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Broadridge Financial Solutions has a PEG ratio 2.23, compared with 2.40 for the industry. The company possesses a Growth Score of A.

Cirrus Logic, Inc. (CRUS - Free Report) : This fabless semiconductor company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 1.3% over the last 60 days.

Cirrus Logic has a PEG ratio 0.90, compared with 3.33 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.

See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like